Insulet (NASDAQ:PODD – Free Report) had its price target cut by Citigroup from $330.00 to $319.00 in a research report released on Monday, FlyOnTheWall reports. A number of other equities research analysts also recently issued reports on the stock. Barclays boosted their price objective on shares of Insulet from $292.00 to $329.00 in a research […]
Citigroup Trims Insulet (NASDAQ:PODD) Target Price to $319 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Insulet (NASDAQ:PODD) Price Target Cut to $319 00 kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
GPS Wealth Strategies Group LLC bought a new position in shares of Insulet Co. (NASDAQ:PODD – Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 240 shares of the medical instruments supplier’s stock, valued at approximately $77,000. Other large investors […]
Moody National Bank Trust Division boosted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 23.0% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,480 shares of the medical instruments supplier’s stock after acquiring an additional 651 shares during the period. Moody National […]